SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-060646
Filing Date
2023-03-06
Accepted
2023-03-06 06:22:59
Documents
16
Period of Report
2023-03-06
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d444777d8k.htm   iXBRL 8-K 42802
2 EX-4.1 d444777dex41.htm EX-4.1 94691
3 EX-10.1 d444777dex101.htm EX-10.1 232844
4 EX-99.1 d444777dex991.htm EX-99.1 18330
8 GRAPHIC g444777img002.jpg GRAPHIC 8105
  Complete submission text file 0001193125-23-060646.txt   623969

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA ortx-20230306.xsd EX-101.SCH 2517
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE ortx-20230306_lab.xml EX-101.LAB 17802
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ortx-20230306_pre.xml EX-101.PRE 11182
10 EXTRACTED XBRL INSTANCE DOCUMENT d444777d8k_htm.xml XML 3590
Mailing Address 245 HAMMERSMITH ROAD, 3RD FLOOR LONDON X0 W6 8PW
Business Address 245 HAMMERSMITH ROAD, 3RD FLOOR LONDON X0 W6 8PW 011-44-0-203-3846700
Orchard Therapeutics plc (Filer) CIK: 0001748907 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38722 | Film No.: 23707482
SIC: 2836 Biological Products, (No Diagnostic Substances)